The aim of this paper is to report on the development of a Multiple Criteria Decision Analysis (MCDA) Model that was implemented to optimize the location selection for a new healthcare centre. The paper demonstrates how MCDA was used within healthcare to enhance the robustness and transparency...

April 2009 was an important period for all National Health Service (NHS) Community Health Services (CHS) organisations as they were formally separated from the commissioning service in the Primary Care Trust (PCT). This had many implications, including the need to establish individual board,...

This paper presents findings from an action research intervention in the outpatient department of a National Health Service (NHS) Hospital. It investigates the perceived and actual problems of performance measurement, specifically measuring capacity, at a United Kingdom (UK) hospital. An action...

The United Kingdom's publicly funded National Health Service (NHS) is entering a period of transition due to a growth in private healthcare providers. In response, the NHS must become more competitive; identifying competitive advantage, best practice and adopting formal management methods. The...

The aim of this thesis is to help the RM industry avoid misguidedly investing in technologies that are unlikely to be cost-effective and reimbursed by healthcare providers. Health economics provides the tools to demonstrate value for money. These tools are typically used by healthcare providers...

This paper examines whether or not hospital competition in a market with fixed reimbursement prices can prompt improvements in clinical quality. In January 2006, the British Government introduced a major extension of their market-based reforms to the English National Health Service. From January...

This paper investigates how regulation impinges on the launch strategies of international pharmaceutical corporations for new molecules and generics across the main OECD markets during 1960-2008. Comprehensive IMS data is used to analyze the international diffusion of 845 molecules from 14...

This paper examines whether or not hospital competition in a market with fixed reimbursement prices can prompt improvements in clinical quality. In January 2006, the British Government introduced a major extension of their market-based reforms to the English National Health Service. From January...

Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...

While recent research has explored the phenomenon of drug parallel trade in regulated environments such as the European Union (EU), or the European Economic Area, little is known about the mechanisms that explain its origin or the role of the distribution chain in exporting and importing...